Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Enhancement of Local and Systemic Anti-Prostate Cancer Immune Responses

NCT03649841 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT03649841
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03649841 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Enhancement of Local and Systemic Anti-Prostate Cancer Immune Responses
Lead sponsor
University of Washington
Phase
Phase 2
Overall status
Terminated
Start date
June 29, 2020
Completion date
February 1, 2023
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

castration-sensitive prostate carcinoma, metastatic malignant neoplasm in the bone, metastatic prostate carcinoma, prostate adenocarcinoma, prostate small cell neuroendocrine carcinoma, stage iv prostate cancer ajcc v8, stage iva prostate cancer ajcc v8, stage ivb prostate cancer ajcc v8